GLP-1 Drugs Make Promising Debut in TAVR, Carotid Artery Stenting

GLP-1 Drugs Make Promising Debut in TAVR, Carotid Artery Stenting

Summary

Outcomes improved among structural heart and carotid revascularization populations

Description

Outcomes improved among structural heart and carotid revascularization populations

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage